Bird flu, or avian influenza A(H5N1), continues to pose risks, prompting research on a new intranasal vaccine. A recent phase 1 trial showed promising immune responses, especially at lower doses. However, results do not confirm effectiveness against wild subtypes, and… Read More »Intranasal vaccine for bird flu shows success in phase 1 trial
The 2024-2025 flu season in the USA has led to increased hospitalizations and deaths, surpassing COVID rates. Severe complications, including neurologic issues in children and pneumonia from superbugs in adults, are reported. Low vaccination rates contribute to the ongoing crisis.… Read More »2024-2025 flu season is becoming more intense
The CDC’s MMWR was temporarily halted due to a communication pause by the Trump administration, marking a first in its 60-year history. This delay hindered dissemination of crucial information regarding H5N1 and H5N9 avian flu subtypes, raising concerns about potential… Read More »CDC journal, MMWR, resumes publication without H5N1 articles
A highly pathogenic bird flu outbreak, H5N9, has emerged in California, leading to the culling of nearly 119,000 birds. This subtype, distinct from H5N1, has not infected humans yet but poses potential risks due to genetic mutations. Monitoring is crucial,… Read More »H5N9 outbreak in California — a highly pathogenic bird flu subtype